Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Isaac Barchas
AddedFeb 18, 2024
UpdatedMay 31, 2026
Isaac Barchas

Isaac Barchas

Co-Founder, Research Bridge Partners

CrunchbaseLinkedInThe Org

Isaac Barchas's Career

Research Bridge Partners
Research Bridge Partners

Austin, TX, US

Co-Founder
Eradivir
Eradivir

West Lafayette, IN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Isaac Barchas's Career

Research Bridge Partners
Research Bridge Partners
Investment FirmInvestment Firm72016Austin, TX, US
Co-Founder

Leadership at Research Bridge Partners

Reid HoffmanReid HoffmanCo-Founder

Similar to Research Bridge Partners

Beta Bridge CapitalBeta Bridge CapitalPrinceton, NJ, USest. 2015Beta Bridge CapitalPrinceton, NJ, US · est. 2015

Seed-stage venture capital fund, Beta Bridge Capital, specializes in emerging ecosystems.

Investment Firm3
UniseedUniseedBrisbane, Queensland, AUest. 2000UniseedBrisbane, Queensland, AU · est. 2000

Uniseed Ventures: A technology fund transforming research into commercial intellectual property since 2000.

Investment Firm15
Middle Bridge PartnersMiddle Bridge PartnersWashington, D.C., DC, USMiddle Bridge PartnersWashington, D.C., DC, US

Middle Bridge Partners: A private equity firm investing in emerging companies for a global future.

Investment Firm5
Fairbridge ParkFairbridge ParkNew York City, NY, USest. 2021Fairbridge ParkNew York City, NY, US · est. 2021

Fairbridge Park: A tech-enabled investor partnering with mission-driven entrepreneurs to address socioeconomic issues.

Investment Firm6
Eradivir
Eradivir
Angel$256k92020West Lafayette, IN, US
Board Member· Board

Leadership at Eradivir

Martin LowMartin LowCo-Founder
Philip S. LowPhilip S. LowCo-Founder

Similar to Eradivir

Exavir TherapeuticsExavir TherapeuticsAntiviral Therapeuticsest. 2020Exavir Therapeuticsest. 2020

Exavir Therapeutics: A preclinical biotech firm focused on eradicating HIV and other viruses through nanomedicine.

Seed · $7M3
CoviCept TherapeuticsCoviCept TherapeuticsSan Diego, CA, USTherapeuticsest. 2020CoviCept TherapeuticsSan Diego, CA, US · est. 2020

Developing small molecule to inhibit RNA virus spread.

Seed · $2.3M6
Evrys BioEvrys BioDoylestown, PA, USAntiviral Therapyest. 2012Evrys BioDoylestown, PA, US · est. 2012

US-based Evrys Bio enhances sirtuins' natural ability to combat infections with unique antiviral therapy.

Series C · $34.8M18
IconOVir BioIconOVir BioSan Diego, CA, USOncolytic Virusest. 2018IconOVir BioSan Diego, CA, US · est. 2018

IconOVir Bio: A preclinical biotech firm innovating personalized oncolytic virus cancer therapies.

Series A · $77M8

Isaac Barchas's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · Dunamu

People Similar to Isaac Barchas

Chris KomelaskyChris KomelaskyFounder · SiteBridge ResearchDaniel P. MyersDaniel P. MyersBoard Member · Bridge BankCharles RobertsCharles RobertsFounder & CEO · Loxbridge ResearchChris BourdonChris BourdonBoard Member · NewBridge Global VenturesGregory VandenBoschGregory VandenBoschCo-Founder · HealthBridgeLalit JanakLalit JanakCo-Founder · Bridge Money